TickrTrends DXCM fair value analysis

Why Bellevue Sees Medtech Stocks Making a Comeback

finews.asia · 2026-09-04

Medtech stocks were among the losers of the AI boom for a long time. Bellevue Asset Management, however, believes the fundamental growth story remains intact and sees the first signs that a turnaround is already under way.

Read the full story at finews.asia →

Is DXCM undervalued? See TickrTrends' fair value analysis →